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Capsule Summary 34 
 35 
TTC7A deficiency typically causes severe gastrointestinal manifestations such as 36 
multiple intestinal atresia or early onset inflammatory bowel disease. In some cases 37 
this is associated with severe combined immunodeficiency. Partial loss-of-function 38 
mutations appear to be associated with a milder phenotype resulting in common 39 
variable immunodeficiency-like condition with enteropathy. 40 
 41 
 42 
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To the Editor: 48 
Biallelic mutations in tetratricopeptide repeat domain 7A (TTC7A) gene have 49 
been shown to cause several overlapping clinical phenotypes. These include multiple 50 
intestinal atresia (MIA) with various degrees of combined immunodeficiency (CID) 51 
(1), severe form of very early onset inflammatory bowel disease, apoptotic 52 
enterocolitis (AE) (2) and immune deficiency–related enteropathy-lymphocytopenia-53 
alopecia (ELA) syndrome (3). All affected individuals reported to date have presented 54 
in first few months of life and all suffered severe life-threatening gastrointestinal (GI) 55 
and/or immunological disease manifestations. In the case of MIA, surgical 56 
intervention is often necessary early in life. Disease progression and relapses of 57 
atresia and stenosis in many patients requires repeat surgeries and small bowel 58 
transplantation (4). Many patients with enteropathy required total parenteral nutrition 59 
(TPN). Immunological studies of these patients showed varying degrees of 60 
hypogammaglobulinemia and lymphopenia which in some cases was consistent with 61 
a diagnosis of severe combined immunodeficiency (SCID).  62 
Here we report a case presenting with clinical features consistent with 63 
Common Variable Immunodeficiency (CVID) and enteropathy, but was later found to 64 
have compound heterozygous mutations in TTC7A. The patient presented at the age of 65 
15 with lethargy, pallor and a low body mass index. He was found to be anaemic and 66 
had low levels of ferritin, folate, calcium and Vitamin D. He did not report any overt 67 
diarrhoea, abdominal pain or other symptoms suggestive of small bowel obstruction. 68 
He also had no prior history of recurrent or unusual infections. An oesophago-69 
gastroduodenoscopy showed an atrophic duodenal mucosa, there was no evidence of 70 
any atresia. Histology showed variable villous atrophy and marked lymphocytosis 71 
(Fig 1, C) with absence of plasma cells. He was found to have severe 72 
panhypogammaglobulinaemia with normal T and B cell numbers but almost absent 73 
class-switched memory B cells. Further investigations showed normal proliferative T 74 
cell response to PHA and anti-CD3 stimulation and normal neutrophil function tests 75 
(Table E1). The features were consistent with diagnosis of CVID; coeliac disease 76 
could not be excluded. Gluten free diet had only a modest effect at alleviating his 77 
symptoms. Although he had no history of infections, due to the severity of his 78 
panhypogammaglobulinaeamia he was commenced on immunoglobulin replacement 79 



































































following an admission for diabetic ketoacidosis. He remains free from infections, but 81 
continues to have difficulties with malabsorption and poor weight gain. 82 
The patient gave consent to participate in a study investigating molecular 83 
causes of primary immunodeficiencies. Two mutations in TTC7A were identified by 84 
whole exome sequencing (WES): rs139010200, exon 16/20 c.1817 aAg/aGg 85 
(K606R); and rs149602485, exon 17/20 c.2014 Tct/Cct (S672P). Sanger sequencing 86 
confirmed TTC7A variants in the proband as well as heterozygosity of A1817G 87 
paternally and T2014C maternally (Fig 1, B). No inheritance of affected alleles 88 
occurred in healthy siblings (Fig E1) (for methods please see online supplement).  89 
These SNVs have been reported previously by Chen et al. (patient F5-A) on 90 
the maternal allele of European descent and in combination with exon 7 91 
c.1000DAAGT on the paternal allele of French-Canadian descent (1). Samuels et al. 92 
also report this same 4-nt deletion in a number of unrelated French-Canadian patients 93 
with MIA (5). We suspect that compound heterozygous combination of K606R and 94 
S672P leads to a mild form of disease although we have not identified a clear 95 
mechanism by which this occurs. Confirmed pathogenicity of these variants will 96 
require in-depth functional analysis and reports of other similar instances.  97 
The biological functions of TTC7A in MIA have been reviewed by L. 98 
Notarangelo (6) where this protein is suggested to act as a repressor of RhoA 99 
signalling. The administration of ROCK inhibitors is thought to ameliorate 100 
proliferative activity and epithelial architecture of the lumen and intestinal crypts. 101 
Avitzur et al. identify phosphatidylinositol 4-kinase IIIa (PI4KIIIa) as a major 102 
TTC7A-interacting protein (2). The protein EFR3 homolog B (EFR3B) tethers 103 
TTC7A to the plasma membrane thereby allowing localisation of PI4KIIIa at the cell 104 
membrane. In adult mice the inactivation of murine PI4KIIIa leads to death due to 105 
necrosis of enterocytes in the villi and intestinal crypts (7). However, the key 106 
immunological features of thymic dysplasia and lymphoid depletion in MIA-CID 107 
have not yet been explained.  108 
The patient we presented here has a much milder clinical phenotype both in 109 
terms of his immunological and GI disease manifestations. We wondered if TTC7A 110 
variants found in this patient might have less detrimental effects on the function of the 111 
protein. To assess protein expression levels immunohistochemistry was performed on 112 
the patient’s small intestine biopsy using rabbit polyclonal TTC7A antibody 113 



































































1, D and E and F). No reduction in protein expression was seen. K606R is reported in 115 
EXAC with allele frequency 0.002061 including as homozygous. Given the mild 116 
phenotype presented here it is not likely that this SNP alone produces a noticeable 117 
effect. A loss of fully functional protein may occur in combination with S672P 118 
without any visible reduction in expression. Genome, exome, and clinical panel 119 
sequencing in rare diseases generally requires filtering of common SNPs. The 120 
contribution toward disease due to mutations with allele frequency greater than 0.001 121 
occurring in a biallelic state may be neglected in cases such as this.  122 
Known variants associated with disease are shown in Table 1 and notated on 123 
the gene representation (Fig 1, A). This presents an updated list originally compiled 124 
by Yang et al. (8). These variants were mapped on a model of the predicted TTC7A 125 
protein structure in Fig E2. Modelling was based on the recently reported crystal 126 
structure of TTC7B (9) which has high sequence similarity to TTC7A. This reference 127 
data was combined with that of other tetratricopeptide repeat (TPR) domains found in 128 
a large number of proteins (6) (supplemental report E3 and E4). A confidence of 714 129 
residues (81%) was modeled at >90% accuracy. The TPR domains are identified as 130 
cartoons on the ribbon structure (Fig E2).  131 
The variants K606R and S672P have been described in patients as pathogenic 132 
but always in association with another more severe alteration. From our model, K606 133 
and S672 lie buried on the beta-turn-beta between TPR domains 6/7 and may not be 134 
involved in major interactions resulting in a milder phenotype compared to other 135 
variants in the surrounding region.  136 
Limited in vivo models exist for this condition but it is hopeful that models of 137 
human intestine using pluripotent stem cells could allow greater functional study of 138 
TTC7A. A precise mechanism shared between gut development and robust immune 139 
function is yet to be identified. Our case expands the clinical phenotype associated 140 
with biallelic TTC7A mutations. Enteropathy is a relatively common complication of 141 
CVID, and as we continue to use more advanced genetic techniques to study this 142 
condition, it is possible that these less severe TTC7A variants will be found more 143 
frequently in this patient population.  144 
  145 
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Fig 1. Representation of TTC7A pathogenic variants with genetic and pathological 184 
findings. (A) Representation of the TTC7A gene and position of mutations identified 185 
to date in apoptotic enterocolitis, multiple intestinal atresias, combined 186 
immunodeficiency, and enteropathy-lymphocytopenia-alopecia. Vertical bars: Protein 187 
changes, purple; stop codon, red; frame shift, green; exon skipping, curved arrows 188 
between orange bars; retained intron, blue. Horizontal bars: Tetratricopeptide repeat 189 
domains (1-9) 121 – 157 and 177 – 210 Red, 414 – 447 orange, 497 – 531 yellow, 190 
533 – 565 Green, 566 – 599 Cyan, 745 – 778 Blue, 780 – 812 Purple, 813 – 846 191 
Magenta. (B) Pedigree and mutation inheritance pattern. (C) Gastrointestinal 192 
pathology. Duodenal biopsy with subtotal villous atrophy, marked crypt hyperplasia 193 
and villous tip lymphocytosis.  Goblet and Paneth cells are preserved. 20x Higher 194 
magnification – shortened villi with lymphocytosis and conspicuous lack of plasma 195 
cells within the lamina propria. (D) Immunohistochemistry of the patient’s small 196 



































































Hyperplasia is evident in comparison with healthy control (E). No reduction in protein 198 
expression was seen. (F) Patient biopsy control with no primary antibody.  199 
 200 
Fig E1. Sanger sequence electropherogram of pedigree. 201 
Sanger sequence electropherogram of the proband II.ii for exon 16/20 c.1817 202 
aAg/aGg  (K606R) and exon 17/20 c.2014 Tct/Cct (S672P). Heterozygosity of 203 
A1817G paternally I.i and T2014C maternally I.ii. Healthy siblings II.i, II.iii and II.iv 204 
(arranged by age left to right on pedigree) show no presence of affected alleles.  205 
  206 
Fig E2. Ribbon structure model of TTC7A and tetratricopeptide repeat domains. All 207 
known pathogenic variants in apoptotic enterocolitis, multiple intestinal atresias, 208 
combined immunodeficiency, and enteropathy-lymphocytopenia-alopecia are 209 
mapped. Annotation colors match that of the gene representation of Figure 1 A. 210 
Protein changes, purple; stop codon, red; frame shift, green; exon skipping causing 211 
variants, orange; retained intron, blue. Tetratricopeptide repeat domains (TPR) are 212 
identified as cartoons also corresponding to horizontal bars shown in Figure 1 A. 213 
Tetratricopeptide repeat domains (1-9) 121 – 157 and 177 – 210 Red, 414 – 447 214 
orange, 497 – 531 yellow, 533 – 565 Green, 566 – 599 Cyan, 745 – 778 Blue, 780 – 215 
812 Purple, 813 – 846 Magenta. 216 
 217 
E3. Modeling report. 218 
Detailed template report for data used with Phyre2 software indicating alignment, 219 
coverage, confidence and % i.d. Template Information 1-20 used for model 220 
construction.  221 
 222 
E4. Sequence structure report. 223 
Phyre2 software report of secondary structure and disorder prediction showing 224 



































































Figure 1 Click here to download Figure Figure 1.tiff 
Table 1. Genetic variants related to MIA-CID, AE, or ELA reported to date. 
 
 
*Ngan et al.  independently report on the same case as Avitzur et al. with further work on WGS, thymus and lung pathology. Further features relating to phenotypes 
may be reported in indiviual references. **The dermatological phenotypes of Patients C3 and E3 in Bigorgne et al. have also been recently reported (E). AE, 
Apoptotic enterocolitis; MIA, Multiple intestinal atresias;  CID Combined immunodeficiency; ELA, Enteropathy-lymphocytopenia-alopecia; CH, compound 
heterozygous; Homo, homozygous.  
 
Region Nucleotide Amino acid Variant affect Population Phenotype Reference Family ID per ref Inheritance Type
Exon 2 G214A E71K Missense Caucasians /Sudanese AE, CID, No atresia Avitzur/Ngan* 1 CH
Exon 2 G214A E71K Missense - ELA Lemoine F1 Homo/consanguineous
Skipping of 2–3 del Ex2c.185_348 del D62_S116 Exon skipping Mixed European MIA-CID Bigorgne A CH
Skipping of 2 del Ex2c.185_517 del D62_G173 Exon skipping Mixed European MIA-CID Bigorgne A CH
Exon 2 del Ex2c.313TATC Y105fs Frame shift Serbian MIA-CID Chen 2 Homo
Exon 2 del Ex2c.313TATC Y105fs Frame shift Bosniak MIA-CID Chen 3 Homo/related parents
Skipping of 2–3 Unknown mutations  - Exon skipping Italian MIA-CID Chen 8 Non-consanguineous
Exon 5 AG764A K255fs Frame shift - MIA-CID Chen 4 CH
Exon 6 C833T Q277X Stop Saudi Arabia MIA-CID Bigorgne B Homo/consanguineous
Skipping of 7 844-1G>T - Exon skipping Caucasians AE, MIA-CID Avitzur 2 CH
Exon 7 delEx7c.911T L304fsX59 Frame shift - ELA Lemoine F2 P3 CH
Skipping of 7 del Ex7c.1000_1003AAGT - Exon skipping French-Canadian and Mixed European MIA-CID Chen 5 CH
Skipping of 7 del Ex7c.1000_1003AAGT - Exon skipping French-Canadian MIA Samuels F1 F4 F6 Homo
Skipping of 7 del Ex7c.1000_1003AAGT - Exon skipping French-Canadian/English MIA-CID Samuels F7 CH
Skipping of 7 del Ex7c.1000_1003AAGT - Exon skipping French-Canadian MIA-CID Fernandez F Homo
Skipping of 7 del Ex7c.1000_1003AAGT - Exon skipping French-Canadian MIA-CID Fernandez P2 CH
Exon 8 C1111G Y337X Stop Mixed European MIA-CID Bigorgne E CH
Exon 9 T1198C L400P Missense Italian MIA-CID Chen 7 Homo
Skipping of 10 Ex10c.1204-2A>G - Exon skipping Caucasians AE, MIA-CID Avitzur 2 CH
Skipping of 12 Exon11 - 4 bp deletion  - Exon skipping Norway MIA-CID Bigorgne D CH
Skipping of 12 Intron12c.1510+105T-A del L465-A504 Exon skipping Mixed European MIA Bigorgne F CH
Exon 12 1433T>C L478P Missense - ELA Lemoine F2 P3 CH
Exon 12 del Ex12c.1479G L493fsX13 Frame shift Mixed European MIA-CID Bigorgne** E CH
Exon 14 C1576T Q526X Stop Caucasians /Sudanese AE, CID, No atresia Avitzur/Ngan* 1 CH
Exon 14 C1616T S539L Missense Norway MIA-CID Bigorgne D CH
Exon 15 1652C>A A551D Missense Irish/Ashkenazi  Jew MIA-CID Agarwal F1 CH
Exon 15 Ins Ex15c.1673G A558GfsX7 Frame shift Mixed European MIA Bigorgne F CH
Ex 16 Read-through intron del Ex16c.1919+1G>A - Retained intron Arabic MIA-CID Chen 1 Homo/consanguineous
Exon 16 A1817G K606R Missense French-Canadian and Mixed European MIA-CID Chen 5 CH
Exon 16 A1817G K606R Missense European CVID and enteropathy Presented here - CH
Skipping of 17 1920-2A>G - Exon skipping Malay MIA-CID Yang F1d CH
Exon 17 T2014C S672P Missense French-Canadian and Mixed European MIA-CID Chen 5 CH
Exon 17 T2014C S672P Missense European CVID and enteropathy Presented here - CH
Exon 18 C2033A S678X Stop Italian MIA-CID Chen 6 CH
Exon 18 C2134T Q712X Stop Italian MIA-CID Chen 6 CH
Exon 20 T2468C L823P Missense - MIA-CID Chen 4 CH
Exon 20 T2468C L823P Missense French-Canadian MIA-CID Fernandez P2 CH
Exon 20 T2468C L823P Missense French-Canadian/English MIA-CID Samuels F7 CH
Exon 20 C2482T Q828X Stop Irish/Ashkenazi  Jew MIA-CID Agarwal F1 CH
Exon 20 del 2496-2497 CG A832fsX1 Frame shift Sri Lanka MIA-CID Bigorgne** C Homo/likely consanguineous
Exon 20 G2494A A832T Missense - AE, No CID, No atresia Avitzur 3 Homo
Exon 20 G2569T E857X Stop Malay MIA-CID Yang F1d CH
Table 1 Click here to download Table Table 1 and Summary.docx 
Supplemental references:  
A. Bigorgne AE, Farin HF, Lemoine R, Mahlaoui N, Lambert N, Gil M, et al. TTC7A mutations disrupt intestinal epithelial apicobasal polarity. The Journal of 
clinical investigation. 2014;124(1):328-37. 
B. Fernandez I, Patey N, Marchand V, Birlea M, Maranda B, Haddad E, et al. Multiple intestinal atresia with combined immune deficiency related to TTC7A 
defect is a multiorgan pathology: study of a French-Canadian-based cohort. Medicine. 2014;93(29):e327. 
C. Agarwal NS, Northrop L, Anyane-Yeboa K, Aggarwal VS, Nagy PL, Demirdag YY. Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with 
multiple intestinal atresia and combined immunodeficiency. Journal of clinical immunology. 2014;34(6):607-10. 
D.  Ngan, B., et al., Mutations in tetratricopeptide repeat domain 7A (TTC7A) are associated with combined immunodeficiency with dendriform lung ossification but 
no intestinal atresia. LymphoSign Journal, 2014. 01(01): p. 10-26 
E.  Leclerc-Mercier, S., Lemoine, R., Bigorgne, A.E., Sepulveda, F., Leveau, C., Fischer, A., Mahlaoui, N., Hadj-Rabia, S. and de Saint Basile, G. 2016. Ichthyosis as the 




Fig E1 Click here to download Electronic Supplemental Material (ESM)
Figure E1.tif













# Template Alignment Coverage 3D Model Confidence % i.d. Template Information
1 c5dseC_ Alignment 100.0 52
PDB header:protein binding
Chain: C: PDB Molecule:tetratricopeptide repeat protein 7b;
PDBTitle: crystal structure of the ttc7b/hyccin complex
2 c5dseA_ Alignment 100.0 57
PDB header:protein binding
Chain: A: PDB Molecule:tetratricopeptide repeat protein 7b;
PDBTitle: crystal structure of the ttc7b/hyccin complex
3 c4bujF_ Alignment 100.0 13
PDB header:hydrolase
Chain: F: PDB Molecule:superkiller protein 3;
PDBTitle: crystal structure of the s. cerevisiae ski2-3-8 complex
4 c4hnxA_ Alignment 100.0 11
PDB header:transferase
Chain: A: PDB Molecule:n-terminal acetyltransferase a complex
subunit nat1;
PDBTitle: the nata acetyltransferase complex bound to ppgpp
5 c5ganJ_ Alignment 100.0 13
PDB header:transcription
Chain: J: PDB Molecule:pre-mrna-splicing factor 6;
PDBTitle: the overall structure of the yeast spliceosomal u4/u6.u5
tri-snrnp at2 3.7 angstrom
6 c4kvmA_ Alignment 100.0 10
PDB header:transferase/transferase inhibitor
Chain: A: PDB Molecule:n-terminal acetyltransferase a complex
subunit nat1;
PDBTitle: the nata (naa10p/naa15p) amino-terminal
acetyltransferase complex2 bound to a bisubstrate analog
7 c2xpiA_ Alignment 100.0 13
PDB header:cell cycle
Chain: A: PDB Molecule:anaphase-promoting complex subunit
cut9;
PDBTitle: crystal structure of apc/c hetero-tetramer cut9-hcn1
8 c4uzyA_ Alignment 100.0 12
PDB header:motor protein
Chain: A: PDB Molecule:flagellar associated protein;
PDBTitle: crystal structure of the chlamydomonas ift70 and ift52
complex
9 c4ui9K_ Alignment 100.0 17
PDB header:cell cycle
Chain: K: PDB Molecule:cell division cycle protein 16 homolog;
PDBTitle: atomic structure of the human anaphase-promoting
complex




11 c4ui9C_ Alignment 100.0 12
PDB header:cell cycle
Chain: C: PDB Molecule:cell division cycle protein 23 homolog;
PDBTitle: atomic structure of the human anaphase-promoting
complex
Fig E3 Click here to download Electronic Supplemental Material
(ESM) Figure E3 Modelling report.pdf
12 c4n5cH_ Alignment 100.0 12
PDB header:protein binding
Chain: H: PDB Molecule:cargo-transport protein ypp1;
PDBTitle: crystal structure of ypp1
13 c4ui9Y_ Alignment 100.0 13
PDB header:cell cycle
Chain: Y: PDB Molecule:anaphase-promoting complex subunit 7;
PDBTitle: atomic structure of the human anaphase-promoting
complex
14 c4rg6B_ Alignment 100.0 14
PDB header:protein binding
Chain: B: PDB Molecule:cell division cycle protein 27 homolog;
PDBTitle: crystal structure of apc3-apc16 complex
15 c3fp4A_ Alignment 100.0 15
PDB header:transport protein
Chain: A: PDB Molecule:tpr repeat-containing protein yhr117w;
PDBTitle: crystal structure of tom71 complexed with ssa1 c-
terminal2 fragment
16 c4hotA_ Alignment 100.0 15
PDB header:rna binding protein/rna
Chain: A: PDB Molecule:interferon-induced protein with
tetratricopeptide repeats
PDBTitle: crystal structure of full-length human ifit5 with 5`-
triphosphate2 oligoadenine
17 c4e85B_ Alignment 100.0 8
PDB header:structural protein
Chain: B: PDB Molecule:mrna 3'-end-processing protein rna14;
PDBTitle: crystal structure of hat domain of rna14




19 c5aioA_ Alignment 100.0 12
PDB header:transcription
Chain: A: PDB Molecule:transcription factor tau 131 kda subunit;
PDBTitle: crystal structure of t131 n-terminal tpr array
20 c2y4tA_ Alignment 100.0 15
PDB header:chaperone
Chain: A: PDB Molecule:dnaj homolog subfamily c member 3;
PDBTitle: crystal structure of the human co-chaperone p58(ipk)
21 c2gw1A_ Alignment not modelled 100.0 14
PDB header:protein transport
Chain: A: PDB Molecule:mitochondrial precursor proteins import
receptor;
PDBTitle: crystal structure of the yeast tom70
22 c4ebaC_ Alignment not modelled 100.0 9
PDB header:structural protein/rna binding protein
Chain: C: PDB Molecule:mrna 3'-end-processing protein rna14;
PDBTitle: crystal structure of the rna14-rna15 complex
23 c3iegB_ Alignment not modelled 100.0 16
PDB header:chaperone
Chain: B: PDB Molecule:dnaj homolog subfamily c member 3;
PDBTitle: crystal structure of p58(ipk) tpr domain at 2.5 a
24 c4g1tB_ Alignment not modelled 100.0 13
PDB header:antiviral protein
Chain: B: PDB Molecule:interferon-induced protein with
tetratricopeptide repeats
PDBTitle: crystal structure of interferon-stimulated gene 54
25 c4m57A_ Alignment not modelled 100.0 11
PDB header:rna binding protein
Chain: A: PDB Molecule:chloroplast pentatricopeptide repeat
protein 10;
PDBTitle: crystal structure of the pentatricopeptide repeat protein
ppr10 from2 maize
26 c4ui9O_ Alignment not modelled 100.0 12
PDB header:cell cycle
Chain: O: PDB Molecule:anaphase-promoting complex subunit 5;
PDBTitle: atomic structure of the human anaphase-promoting
complex
27 c3v6pA_ Alignment not modelled 99.9 14
PDB header:dna binding protein
Chain: A: PDB Molecule:dhax3;
PDBTitle: crystal structure of the dna-binding domain of dhax3, a
tal effector
28 c2uy1A_ Alignment not modelled 99.9 12
PDB header:rna-binding protein
Chain: A: PDB Molecule:cleavage stimulation factor 77;
PDBTitle: crystal structure of cstf-77




30 c1fchB_ Alignment not modelled 99.9 16
PDB header:signaling protein
Chain: B: PDB Molecule:peroxisomal targeting signal 1 receptor;
PDBTitle: crystal structure of the pts1 complexed to the tpr region2
of human pex5
31 c3hymB_ Alignment not modelled 99.9 11
PDB header:cell cycle, ligase
Chain: B: PDB Molecule:cell division cycle protein 16 homolog;
PDBTitle: insights into anaphase promoting complex tpr
subdomain2 assembly from a cdc26-apc6 structure
32 c4zlhB_ Alignment not modelled 99.9 13
PDB header:metal binding protein
Chain: B: PDB Molecule:lipopolysaccharide assembly protein b;
PDBTitle: structure of the lapb cytoplasmic domain at 2 angstroms




34 c4r7sA_ Alignment not modelled 99.9 11
PDB header:structural genomics, unknown function
Chain: A: PDB Molecule:tetratricopeptide repeat protein;
PDBTitle: crystal structure of a tetratricopeptide repeat protein
(parmer_03812)2 from parabacteroides merdae atcc 43184 at 2.39
a resolution
35 c3cvpA_ Alignment not modelled 99.9 15
PDB header:transport protein
Chain: A: PDB Molecule:peroxisome targeting signal 1 receptor
pex5;
PDBTitle: structure of peroxisomal targeting signal 1 (pts1) binding2
domain of trypanosoma brucei peroxin 5 (tbpex5)complexed3 to
pts1 peptide (10-skl)
36 c4eqfA_ Alignment not modelled 99.9 17
PDB header:protein binding/transport protein
Chain: A: PDB Molecule:pex5-related protein;
PDBTitle: trip8b-1a#206-567 interacting with the carboxy-terminal
seven residues2 of hcn2
37 c4jspA_ Alignment not modelled 99.9 16
PDB header:transferase
Chain: A: PDB Molecule:serine/threonine-protein kinase mtor;
PDBTitle: structure of mtordeltan-mlst8-atpgammas-mg complex
38 c3pe3D_ Alignment not modelled 99.9 18
PDB header:transferase
Chain: D: PDB Molecule:udp-n-acetylglucosamine--peptide n-
PDBTitle: structure of human o-glcnac transferase and its complex
with a peptide2 substrate
39 c2uy1B_ Alignment not modelled 99.9 13
PDB header:rna-binding protein
Chain: B: PDB Molecule:cleavage stimulation factor 77;
PDBTitle: crystal structure of cstf-77
40 c3mkrA_ Alignment not modelled 99.9 12
PDB header:transport protein
Chain: A: PDB Molecule:coatomer subunit epsilon;
PDBTitle: crystal structure of yeast alpha/epsilon-cop subcomplex
of the copi2 vesicular coat




42 c3draA_ Alignment not modelled 99.9 10
PDB header:transferase
Chain: A: PDB Molecule:protein
PDBTitle: candida albicans protein geranylgeranyltransferase-i2
complexed with ggpp




44 c3v6tA_ Alignment not modelled 99.9 13
PDB header:dna binding protein/dna
Chain: A: PDB Molecule:dhax3;
PDBTitle: crystal structure of the dna-bound dhax3, a tal effector,
at 1.852 angstrom
45 c4gpkI_ Alignment not modelled 99.9 13
PDB header:transcription, peptide binding protein
Chain: I: PDB Molecule:nprr;
PDBTitle: crystal structure of nprr in complex with its cognate
peptide nprx
46 c4ynvA_ Alignment not modelled 99.9 15
PDB header:chaperone
Chain: A: PDB Molecule:acl4;
PDBTitle: assembly chaperone of rpl4 (acl4) (residues 28-338)




48 c3uq3A_ Alignment not modelled 99.9 15
PDB header:chaperone
Chain: A: PDB Molecule:heat shock protein sti1;
PDBTitle: tpr2ab-domain:phsp90-complex of yeast sti1
49 c3jb9R_ Alignment not modelled 99.9 11
PDB header:rna binding protein/rna
Chain: R: PDB Molecule:pre-mrna-splicing factor cwf4;
PDBTitle: cryo-em structure of the yeast spliceosome at 3.6
angstrom resolution
50 c1tnoI_ Alignment not modelled 99.9 12
PDB header:transferase
Chain: I: PDB Molecule:geranylgeranyltransferase type i alpha
subunit;
PDBTitle: rat protein geranylgeranyltransferase type-i complexed
with2 a ggpp analog and a kkksktkcvim peptide derived from k-3
ras4b
51 d1hz4a_ Alignment not modelled 99.9 16
Fold:alpha-alpha superhelix
Superfamily:TPR-like
Family:Transcription factor MalT domain III
52 c3q75A_ Alignment not modelled 99.9 13
PDB header:transferase
Chain: A: PDB Molecule:farnesyltransferase alpha subunit;
PDBTitle: cryptococcus neoformans protein farnesyltransferase in
complex with2 fpt-ii and tkcvvm peptide
53 c4abnA_ Alignment not modelled 99.9 12
PDB header:gene regulation
Chain: A: PDB Molecule:tetratricopeptide repeat protein 5;
PDBTitle: crystal structure of full length mouse strap (ttc5)
54 c2ho1B_ Alignment not modelled 99.8 12
PDB header:protein binding
Chain: B: PDB Molecule:type 4 fimbrial biogenesis protein pilf;
54 c2ho1B_ Alignment not modelled 99.8 12 PDBTitle: functional characterization of pseudomonas aeruginosa
pilf
55 c4lngA_ Alignment not modelled 99.8 14
PDB header:transferase
Chain: A: PDB Molecule:caax farnesyltransferase alpha subunit
ram2;
PDBTitle: aspergillus fumigatus protein farnesyltransferase complex
with2 farnesyldiphosphate and tipifarnib
56 c3mv3B_ Alignment not modelled 99.8 11
PDB header:protein transport
Chain: B: PDB Molecule:coatomer subunit epsilon;
PDBTitle: crystal structure of a-cop in complex with e-cop




58 c4nrhB_ Alignment not modelled 99.8 14
PDB header:chaperone/protein binding
Chain: B: PDB Molecule:chaperone sycd;
PDBTitle: copn-scc3 complex
59 c4xi0E_ Alignment not modelled 99.8 16
PDB header:protein binding
Chain: E: PDB Molecule:magnetosome protein mama;
PDBTitle: mama 41-end from desulfovibrio magneticus rs-1
60 c2hyzA_ Alignment not modelled 99.8 27
PDB header:de novo protein
Chain: A: PDB Molecule:synthetic consensus tpr protein;
PDBTitle: crystal structure of an 8 repeat consensus tpr superhelix2
(orthorombic crystal form)
61 c4houB_ Alignment not modelled 99.8 20
PDB header:rna binding protein
Chain: B: PDB Molecule:interferon-induced protein with
tetratricopeptide repeats
PDBTitle: crystal structure of n-terminal human ifit1
62 c4gyoB_ Alignment not modelled 99.8 11
PDB header:hydrolase
Chain: B: PDB Molecule:response regulator aspartate phosphatase
j;
PDBTitle: crystal structure of rap protein complexed with
competence and2 sporulation factor
63 c3as5A_ Alignment not modelled 99.8 16
PDB header:protein binding
Chain: A: PDB Molecule:mama;
PDBTitle: mama amb-1 p212121
64 c2q7fA_ Alignment not modelled 99.8 14
PDB header:protein binding
Chain: A: PDB Molecule:yrrb protein;
PDBTitle: crystal structure of yrrb: a tpr protein with an unusual
peptide-2 binding site
65 c3q15A_ Alignment not modelled 99.8 13
PDB header:hydrolase/kinase
Chain: A: PDB Molecule:response regulator aspartate phosphatase
h;
PDBTitle: crystal structure of raph complexed with spo0f
66 c1xi4D_ Alignment not modelled 99.8 11
PDB header:endocytosis/exocytosis
Chain: D: PDB Molecule:clathrin heavy chain;
PDBTitle: clathrin d6 coat
67 c3vtxB_ Alignment not modelled 99.8 16
PDB header:protein binding
Chain: B: PDB Molecule:mama;
PDBTitle: crystal structure of mama protein
68 c4a1sB_ Alignment not modelled 99.8 17
PDB header:cell cycle
Chain: B: PDB Molecule:partner of inscuteable;
PDBTitle: crystallographic structure of the pins:insc complex
69 c4d18J_ Alignment not modelled 99.8 12
PDB header:signaling protein
Chain: J: PDB Molecule:cop9 signalosome complex subunit 2;
PDBTitle: crystal structure of the cop9 signalosome
70 c4i1aB_ Alignment not modelled 99.8 11
PDB header:hydrolase
Chain: B: PDB Molecule:response regulator aspartate phosphatase
i;
PDBTitle: crystal structure of the apo form of rapi
71 c4f3vB_ Alignment not modelled 99.8 17
PDB header:protein transport
Chain: B: PDB Molecule:esx-1 secretion system protein ecca1;
PDBTitle: crystal structure of n-terminal domain of ecca1 atpase
from esx-12 secretion system of mycobacterium tuberculosis
72 c3ro2A_ Alignment not modelled 99.8 12
PDB header:protein binding
Chain: A: PDB Molecule:g-protein-signaling modulator 2;
PDBTitle: structures of the lgn/numa complex
73 c3u4tA_ Alignment not modelled 99.8 11
PDB header:structural genomics, unknown function
Chain: A: PDB Molecule:tpr repeat-containing protein;
PDBTitle: crystal structure of the c-terminal part of the tpr repeat-
containing2 protein q11ti6_cyth3 from cytophaga hutchinsonii.
northeast3 structural genomics consortium target chr11b.
74 c2vq2A_ Alignment not modelled 99.8 10
PDB header:structural protein
Chain: A: PDB Molecule:putative fimbrial biogenesis and twitching
PDBTitle: crystal structure of pilw, widely conserved type iv pilus2
biogenesis factor
75 c3urzB_ Alignment not modelled 99.8 15
PDB header:protein binding
Chain: B: PDB Molecule:uncharacterized protein;
PDBTitle: crystal structure of a putative protein binding protein
(bacova_03105)2 from bacteroides ovatus atcc 8483 at 2.19 a
resolution
76 c1wao4_ Alignment not modelled 99.8 13
PDB header:hydrolase
Chain: 4: PDB Molecule:serine/threonine protein phosphatase 5;
PDBTitle: pp5 structure
77 c5djsA_ Alignment not modelled 99.8 18
PDB header:transferase
Chain: A: PDB Molecule:tetratricopeptide tpr_2 repeat protein;
PDBTitle: thermobaculum terrenum o-glcnac transferase mutant -
k341m
78 c4uqzA_ Alignment not modelled 99.8 15
PDB header:protein transport
Chain: A: PDB Molecule:hsie1;
PDBTitle: coevolution of the atpase clpv, the tssb-tssc sheath and2
the accessory hsie protein distinguishes two type vi3 secretion
classes
79 c2r5sB_ Alignment not modelled 99.8 13
PDB header:structural genomics, unknown function
Chain: B: PDB Molecule:uncharacterized protein vp0806;
PDBTitle: the crystal structure of a domain of protein vp0806
(unknown function)2 from vibrio parahaemolyticus rimd 2210633




81 c3sf4B_ Alignment not modelled 99.8 13
PDB header:signaling protein/protein binding
Chain: B: PDB Molecule:g-protein-signaling modulator 2;
PDBTitle: crystal structure of the complex between the conserved
cell polarity2 proteins inscuteable and lgn
82 c3u64A_ Alignment not modelled 99.8 17
PDB header:transport protein
Chain: A: PDB Molecule:protein tp_0956;
PDBTitle: the crystal structure of tat-t (tp0956)
83 c3ulqA_ Alignment not modelled 99.8 9
PDB header:gene regulation/transcription activator
Chain: A: PDB Molecule:response regulator aspartate phosphatase
f;
PDBTitle: crystal structure of the anti-activator rapf complexed with
the2 response regulator coma dna binding domain




85 c2e2eA_ Alignment not modelled 99.7 12
PDB header:lyase
Chain: A: PDB Molecule:formate-dependent nitrite reductase
complex nrfg subunit;
PDBTitle: tpr domain of nrfg mediates the complex formation
between heme lyase2 and formate-dependent nitrite reductase in
escherichia coli o157:h7
86 c5efrA_ Alignment not modelled 99.7 10
PDB header:cell adhesion
Chain: A: PDB Molecule:bama-bamd fusion protein;
PDBTitle: crystal structure of a bama-bamd fusion
87 c5a6cB_ Alignment not modelled 99.7 12
PDB header:cell adhesion
Chain: B: PDB Molecule:g-protein-signaling modulator 2, afadin;
PDBTitle: concomitant binding of afadin to lgn and f-actin directs2
planar spindle orientation
88 c3sz7A_ Alignment not modelled 99.7 16
PDB header:chaperone regulator
Chain: A: PDB Molecule:hsc70 cochaperone (sgt);
PDBTitle: crystal structure of the sgt2 tpr domain from aspergillus
fumigatus
89 c4i2wA_ Alignment not modelled 99.7 19
PDB header:chaperone/protein binding
Chain: A: PDB Molecule:protein unc-45;
PDBTitle: crystal structure of the myosin chaperone unc-45 from
c.elegans in2 complex with a hsp70 peptide
90 c2xcbA_ Alignment not modelled 99.7 19
PDB header:protein binding
Chain: A: PDB Molecule:regulatory protein pcrh;
PDBTitle: crystal structure of pcrh in complex with the chaperone2
binding region of popd
91 c4i17A_ Alignment not modelled 99.7 17
PDB header:structural genomics, unknown function
Chain: A: PDB Molecule:hypothetical protein;
PDBTitle: crystal structure of a tpr repeats protein (bf2334) from
bacteroides2 fragilis nctc 9343 at 1.50 a resolution
92 c2pl2A_ Alignment not modelled 99.7 18
PDB header:protein binding
Chain: A: PDB Molecule:hypothetical conserved protein ttc0263;
PDBTitle: crystal structure of ttc0263: a thermophilic tpr protein in
thermus2 thermophilus hb27
93 c3zpjA_ Alignment not modelled 99.7 12
PDB header:unknown function
Chain: A: PDB Molecule:ton_1535;
PDBTitle: crystal structure of ton1535 from thermococcus
onnurineus na1




95 c4ga0A_ Alignment not modelled 99.7 14
PDB header:transport protein
Chain: A: PDB Molecule:e3 sumo-protein ligase ranbp2;
PDBTitle: structure of the n-terminal domain of nup358
96 c4cgvA_ Alignment not modelled 99.7 15
PDB header:chaperone
Chain: A: PDB Molecule:rna polymerase ii-associated protein 3;
PDBTitle: first tpr of spaghetti (rpap3) bound to hsp90 peptide
srmeevd
97 c3zn3A_ Alignment not modelled 99.7 8
PDB header:cell cycle
Chain: A: PDB Molecule:anaphase-promoting complex subunit 8;
PDBTitle: n-terminal domain of s. pombe cdc23 apc subunit
98 c2vyiA_ Alignment not modelled 99.7 16
PDB header:chaperone
Chain: A: PDB Molecule:sgta protein;
PDBTitle: crystal structure of the tpr domain of human sgt
99 c3gyzB_ Alignment not modelled 99.7 12
PDB header:chaperone
Chain: B: PDB Molecule:chaperone protein ipgc;
PDBTitle: crystal structure of ipgc from shigella flexneri
100 c2c2lD_ Alignment not modelled 99.7 21
PDB header:chaperone
Chain: D: PDB Molecule:carboxy terminus of hsp70-interacting
protein;
PDBTitle: crystal structure of the chip u-box e3 ubiquitin ligase
101 c3ly8A_ Alignment not modelled 99.7 16
PDB header:signaling protein
Chain: A: PDB Molecule:transcriptional activator cadc;
PDBTitle: crystal structure of mutant d471e of the periplasmic
domain of cadc
102 c4cr3Q_ Alignment not modelled 99.7 12
PDB header:hydrolase
Chain: Q: PDB Molecule:26s proteasome regulatory subunit rpn6;
PDBTitle: deep classification of a large cryo-em dataset defines
the2 conformational landscape of the 26s proteasome
103 c4gcoA_ Alignment not modelled 99.7 16
PDB header:protein binding
Chain: A: PDB Molecule:protein sti-1;
PDBTitle: central domain of stress-induced protein-1 (sti-1) from
c.elegans
104 c2kckA_ Alignment not modelled 99.7 16
PDB header:structural genomics, unknown function
Chain: A: PDB Molecule:tpr repeat;
PDBTitle: nmr solution structure of the northeast structural
genomics2 consortium (nesg) target mrr121a
PDB header:chaperone
Chain: A: PDB Molecule:rna polymerase ii-associated protein 3;
105 c4cgwA_ Alignment not modelled 99.7 18
Chain: A: PDB Molecule:rna polymerase ii-associated protein 3;
PDBTitle: second tpr of spaghetti (rpap3) bound to hsp90 peptide
srmeevd




107 c2vsnB_ Alignment not modelled 99.7 18
PDB header:transferase
Chain: B: PDB Molecule:xcogt;
PDBTitle: structure and topological arrangement of an o-glcnac2
transferase homolog: insight into molecular control of3 intracellular
glycosylation




109 c3gw4B_ Alignment not modelled 99.7 15
PDB header:structural genomics, unknown function
Chain: B: PDB Molecule:uncharacterized protein;
PDBTitle: crystal structure of uncharacterized protein from
deinococcus2 radiodurans. northeast structural genomics
consortium target drr162b.
110 c4i1aA_ Alignment not modelled 99.7 11
PDB header:hydrolase
Chain: A: PDB Molecule:response regulator aspartate phosphatase
i;
PDBTitle: crystal structure of the apo form of rapi
111 c2lniA_ Alignment not modelled 99.7 15
PDB header:chaperone
Chain: A: PDB Molecule:stress-induced-phosphoprotein 1;
PDBTitle: solution nmr structure of stress-induced-phosphoprotein 1
sti1 from2 homo sapiens, northeast structural genomics consortium
target hr4403e
112 c4j8dC_ Alignment not modelled 99.6 18
PDB header:chaperone
Chain: C: PDB Molecule:hsc70-interacting protein;
PDBTitle: middle domain of hsc70-interacting protein, crystal form ii
113 c3q49B_ Alignment not modelled 99.6 21
PDB header:ligase/chaperone
Chain: B: PDB Molecule:stip1 homology and u box-containing
protein 1;
PDBTitle: crystal structure of the tpr domain of chip complexed with
hsp70-c2 peptide




115 c3upvA_ Alignment not modelled 99.6 13
PDB header:peptide binding protein
Chain: A: PDB Molecule:heat shock protein sti1;
PDBTitle: tpr2b-domain:phsp70-complex of yeast sti1
116 c2ifuA_ Alignment not modelled 99.6 15
PDB header:endocytosis/exocytosis
Chain: A: PDB Molecule:gamma-snap;
PDBTitle: crystal structure of a gamma-snap from danio rerio
117 c3qdnA_ Alignment not modelled 99.6 14
PDB header:oxidoreductase
Chain: A: PDB Molecule:putative thioredoxin protein;
PDBTitle: putative thioredoxin protein from salmonella typhimurium
118 c4aifA_ Alignment not modelled 99.6 13
PDB header:signaling protein/peptide
Chain: A: PDB Molecule:ah receptor-interacting protein;
PDBTitle: aip tpr domain in complex with human hsp90 peptide
119 c4bt8B_ Alignment not modelled 99.6 12
PDB header:oxidoreductase
Chain: B: PDB Molecule:prolyl 4-hydroxylase subunit alpha-1;
PDBTitle: crystal structure of the apo form of n-terminal domain
and2 peptide substrate binding domain of prolyl-4 hydroxylase3 type
i from human
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Confidence Key
High(9)           Low (0)
? Disordered ( 8%)
Alpha helix ( 70%)
Beta strand ( 0%)
Table 1 Immunological assessments  
Tests 2012 2016 Normal ranges  
IgG (g/l) 2.9 5.4 (on IVIG) 5.4-16.1 
IgA (g/l) 0.07 <0.06 0.8-2.80 
IgM (g/l) 0.18 0.16 0.5-1.90 
IgE ku/l <2.0  0.5-120 
Pneumococcal Ab たg/ml 4.1  Adequate >30 
Total lymphocytes (cells/たl) 1930 1897 1000-2800 
CD3+ Lymphocytes (cells/たl) 1170 1286 800-3500  
CD4+ T cells (cells/たl) 677 664 300-1400 
CD8+ T cells (cells/たl) 420 540 200-900 
cells/たl 
NK cells CD56+ (cells/た)l 97 163 90-600 cells/たl 
B cells (CD19+) cells/たl 570 379 100-500 
cells/たl 
ratio 1.61 1.23 1.07-1.87 
Marginal zone B cells  
CD19+ CD27+ IgD+ (% of CD19+) 
5  0.5-8%* 
Class switched memory B cells 
CD19+ CD27+ IgD- (% of CD19+) 
1  3-18%* 
PHA induced lymphocyte proliferation  Normal N/A 
Anti-CD3 induced lymphocyte 
proliferation 
 Normal N/A 
Neutrophil function test  Normal N/A 
Autoimmune screen [ANA, AMA, 
ACPA, Endomysial Ab (IgG and IgA)]  
Negative  N/A 
PHA: phytohaemagglutinin; ANA: antinuclear antibodies; AMA: antimitochondrial antibodies; 
ACPA: anticitrulinated protein antibodies 
* Schatorje EJ, et al. Age-matched reference values for B-lymphocyte subpopulations and CVID 
classifications in children. Scand J Immunol 2011;74:502-10 
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